becker’s 15th annual spine, orthopedic and pain management

40
Narcotic Diversion Prevention JOHN KARWOSKI, RPh, MBA Becker’s 15th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference June 24, 2017 P20193

Upload: others

Post on 28-Nov-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

Narcotic Diversion PreventionJOHN KARWOSKI, RPh, MBA

Becker’s 15th Annual Spine, Orthopedic

and Pain Management-Driven ASC Conference

June 24, 2017

P20193

DISCLOSURE

Faculty must disclose to participants the existence of any significant

financial interest or any other relationship with the manufacturer of any

commercial product(s) discussed in an educational presentation.

The speaker listed below disclosed a potential conflict of interest.

John Karwoski, RPH, MBA has received financial support from

PharMEDium Services, LLC to serve as a consultant/speaker.

P20193

2

OPIOID ABUSE EPIDEMIC FACTS:

In 2012, Americans, constituting only 4.6% of the world’s

population, have been consuming 80% of the global opioid

supply, and 99% of the global hydrocodone supply1.

P20193

3

OPIOID ABUSE EPIDEMIC FACTS:

In 2012, there were enough opioids prescribed in the US so that every

American could have a full bottle of pills. This is equivalent to medicating

every adult with 5mg of hydrocodone every 6 hours for 45 days2.

P20193

4

OPIOID ABUSE EPIDEMIC FACTS:

Prescription drug abuse leads into opioid abuse. 14% of people who

abuse or who are dependent on pain medication go on to use heroin3.

P20193

5

OPIOID ABUSE EPIDEMIC FACTS:

Approximately 1 in 15 patients will become chronic opioid users

after surgery4.

P20193

6

OPIOID ABUSE EPIDEMIC FACTS:

Approximately one-third of all patients following elective cervical

spine repair surgery were still using opioids 1 year after surgery5.

P20193

7

P20193

8

ADDICTION

A PRIMARY CHRONIC DISEASE

REFLECTED BY AN INDIVIDUAL

PATHOLOGICALLY PURSUING

REWARD/ RELIEF BY SUBSTANCE

USE

ADDICTION IS CHARACTERIZED BY

THE INABILITY TO ABSTAIN FROM THE SOUGHT SUBSTANCE

DRUG DIVERSION

DEFINED AS:

The transfer of any legally prescribed controlled substance from the individual for whom it was prescribed to another person for any illicit use

DIVERSION includes:

• MISSING NARCOTICS

• STAFF MEMBER USING NARCOTICS

• STEALING NARCOTICS

• OVER-PRESCRIBING NARCOTICS

P20193

9

THE OPIOID ABUSE EPIDEMIC HAS PROMPTED THESE ACTIONS:

• DEA has re-written regulation, formed task forces, and is offering training to health care

professionals

• States have begun take-back programs and issued emergency prescribing restrictions

• Prior to filling a narcotic prescription, the Pharmacist must look into a data base to

determine if a patient is a drug seeker or prescriber has any patterns of over prescribing

• Multimodal pain management options are being studied to hopefully reduce opioid use

P20193

10

OTHER EFFORTS TO PREVENT DIVERSION

• DEA Diversion conferences across the US:

https://www.deadiversion.usdoj.gov/mtgs/pharm_awareness/

• DOH surveyors asking for diversion prevention staff education

• Drug diversion coalitions (state level)

• Emergency opioid prescribing restrictions6

• In 2015: 536 bills introduced in 47 states

• In 2016: 434 bills introduced in 46 states

• 9 states limit opioid prescriptions to 7 days (NJ: 5 days)

• 49 states now have a version of a prescription drug monitoring programP20193

11

FRIENDS AND FAMILY

• It’s the responsibility of the prescribing physician to counsel patients on proper use, storage and disposal of

the prescribed drug

• The DEA has pin-pointed that in addition to the potential

for patient RX abuse…7

Family members

Friends

ChildrenAnyone who enters your home can potentially be

involved in or impacted by a diversion event

P20193

12

NARCOTIC TAKE BACK EFFORTS

DEA Take-Back Location Search

• Searchable database of all controlled

substance public disposal locations

• https://www.deadiversion.usdoj.gov/dr

ug_disposal/takeback/

State Take-Back Programs

• Some states have take back initiatives

• Growing trend: the practitioner’s obligation to supply patients with take

back information

P20193

13

COACH PATIENTS ABOUT MEDICATION STORAGE

and PROPER DISPOSAL

• Where will the drugs be stored?

• Who will have access to the drugs?

• What will the patient do with the medication when they’re finished with the prescription?

• Don’t keep a few “just in case” in the house!

• Drop off locations: most municipalities have aMed Drop Box at police stations or fire departments.

P20193

14

HOW DOES DIVERSION AFFECT

EVERYONE IN THE ASC?

PATIENT SAFETY—COMPROMISED

• Employees under the influence of controlled substances are unfit to care for patients

• If an employee has substituted a drug with saline after

diverting, the patient doesn’t receive the intended

dose of the medication

• Partial dose?

• No medication administered at all?

• Risk of infection?

P20193

16

DIVERSION POSES A MASSIVE INFECTION RISK

• Employee injects him/herself witha syringe intended for a patient

• Re-fills syringe with saline and then uses the same syringe on a patient

• Refills vial with saline with the same syringe used for self-injection

• 2009 case led to 5,970 effected patients, 88% tested, 18 positive cases of Hep C8

• Diversion is seen across all kinds of staff

• Surgical technicians

• Nurses

• Physicians

• Managers/ Administrators

P20193

17

Kristen Parker Frederick P. McLeish

Graphic from the Centers for Disease Control and Prevention (CDC) web site https://www.cdc.gov/injectionsafety/drugdiversion/index.html(accessed 2017 May 22)

US Outbreaks Associated with Drug Diversion by Healthcare Professionals, 1983-2013

P20193

THE BEST BARRIER TO DIVERSION BEGINS WITH YOUR MANAGEMENT TEAM!

• A comprehensive and proactive monitoring system: Who, when, what and how to monitor.

• Use of the knowledge and experience of your consultant pharmacist to assist in sourcing or providing education for your staff.

• Engaging in risk analysis programs designed to identify areas of weakness and developing plans of corrective action.

P20193

19

STRATEGIES for Identifying

and Preventing Diversion

in your ASC.

RECOGNIZE WHICH MEDICATIONS ARE CONTROLLED SUBSTANCES

• SCHEDULE I: No current acceptable medical use in the United States

• SCHEDULE II: Substances in this schedule have a high potential for abuse which may lead to severe physical and psychological dependence

• SCHEDULE III: Substances in this schedule have a lower potential for abuse than schedules I/II and may lead to moderate to lower physical and psychological dependence

• SCHEDULE IV: Substances in this schedule have a low potential for abuse

• SCHEDULE V: Substances in this schedule have the lowest potential for abuse and consist mainly of preparations containing limited quantities of narcotics

P20193

21

Facility

places order

Wholesaler

fulfills order

Independent

shipper

sends order

Facility

receives

order

Order is

unpacked

Order is signed into

perpetual

inventory

Medication is issued to

Anesthesia

or Nursing

Unit

Medication is

administered

Can you identify the highest areas of risk?

THE INVENTORY CONTINUUM

P20193

22

PURCHASING AUDITS

• Wholesaler purchasing report

• Compare what was ordered to what was sent to what was received to what was signed into stock

• This audit should be performed by a different individual than who purchases

the narcotics

• How are your DEA 222 forms stored?

• Who has access to CSOS?

P20193

23

DRUG SECURITY

MEASURES• Storage and access of narcotics

• Video surveillance

• Tamper-evident prefilled syringes

• Multi-person audits

• Proper wastage signatures

• Record keeping

• Legibility

• Perpetual inventory bound booklets

• Automation

P20193

24

CANARY VIDEO SURVEILLANCE SYSTEM

• Connects to Wi-Fi and sends

information to your phone

• If it senses anything “out of the

ordinary” you’re notified

immediately with a video of the

event

• Can also watch live

P20193

25

“If you’re not moving forward,

you’re falling back”

Prefilled syringes

• Consistency

• Labeling

• Tamper-evident safety caps

P20193

26

P20193

27

P20193

28

P20193

29

FacilityName:

DateofReview:

#ChartsReviewed:

ConsultantPharmacist:_________________________

MedicalRecord

NumberSedationMedicationAdministered

MatchesChart?

(Y/N)

WastageCo-

Signed(Y/N/NA)

Single-UseVial

Maintained(Y/N)`Comments

NOTES:

MedicalRecordAuditBasicPrinciplesPart1

JDJ

Consultant

P20193

30

P20193

31

JDJ Consulting Risk Analysis

• Core Principles

• Storage and Security

• Procurement

• Ordering / Prescribing

• Preparation / Dispensing

• Administration

• Disposal

• Inventory & Record Keeping

• Surveillance

• Investigation & Response

• Education

• Quality Improvement

Controlled Substance Detection and Prevention Program:

“Elements of Best Practice”

P20193

32

PROPER DISPOSAL OF CONTROLLED SUBSTANCES

• Expired narcotics must be kept secure until they are disposed of or destroyed

• If your state allows for on-site

destruction, you may use either a

chemical digestion agent or an incinerator

• Reverse Distributors can be used in all

50 states

• OR Wastage, i.e. partial syringes and vials

• DO NOT use kitty litter or coffee grounds

• DO NOT flush or shoot down the sink

• DO NOT shoot into the red sharps container

• You have a responsibility to ensurethe controlled substance is notretrievable

• Potential solutions: chemicaldigestion agent

P20193

33

EXPIRED

MEDICATIONS

NARCOTIC

WASTAGE

NARCOTICSNON-

NARCOTICS

HAZARDOUS

WASTE

TRASHCHEMICAL

DIGESTION

REVERSE

DISTRIBUTOR

OR

CHEMICAL

DIGESTION

HAZ. WASTE

RECEPTACLE

REMEMBER:

NEVER SHOOT

LIQUIDS INTO YOUR

SHARPS CONTAINER!

PROPER DISPOSAL OF CONTROLLED SUBSTANCES

P20193

34

BETTER EMPLOYEES

=BETTER ASCs

• Putting up barriers to diversion shows you’re on defense—doing what you can to prevent diversion

from happening

• Hiring employees you feel confident

in and maintaining good lines of

communication helps to ensure that there is no predisposition or cultural

tolerance for diversion

• Staff buy-in to anti-diversion efforts

is key!

P20193

35

IN THE CASE OF SUSPECTED DIVERSION

Contact your consultant pharmacistContact

Notify the DEA after your initial (and timely) investigation

•Complete DEA Form 106 AND notify your local field office in writing

•(21 CFR 131.74 (c))

Notify

File a police reportFile

If your state has a CDS department, notify themNotify

Your consultant pharmacist will be able to help you determine if additional steps are necessaryAssist

P20193

THE DUTY TO REPORT

• All ambulatory surgery centers have a legal AND ethical duty to report drug diversion

• Failure to report may result in:

• Civil and regulatory liability

• Negative publicity

• Jeopardize the surgery center’s license and Medicare participation

• Failure to report puts additional patients at risk

• Releasing a diverter from employment without reporting is illegal!

P20193

37

QUESTIONS?

P20193

38

John Karwoski, RPh, MBAJDJ Consulting, LLC

609-313-7572

[email protected]

[email protected]

www.JDJConsulting.net

P20193

40

1. AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS . (n.d.). The American Society of Interventional Pain Physicians (ASIPP) Fact Sheet .

2. Centers for Disease Control and Prevention. (2014). Opioid Painkiller Prescribing, Where You Live Makes a Difference. Atlanta, GA: Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vitalsigns/opioid-prescribing/.

3. Pacira. (October, 2016). Opioid Abuse Facts. Opioid-reducing Multimodal Pain Strategy Consultant Meeting.

4. Carroll I, et al, A pilot study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2102; 115(3): 694-702. NIH, National Institute on Drug Abuse. Prescription and over-the-counter medications. Drug Facts. Revised Nov 2015. http://www.drugabuse.gov/publications/drugfacts/prescription-over-the-countermedications. Accessed 08/24/16.

5. Reynolds, R., Legakis, J., & Tweedie, J. (2013). Postoperative Pain Management after Spinal Fusion Surgery: An Analysis of the Efficacy of Continuous Infusion of Local Anesthetics. Global Spine Journal,2013(3), 1st ser., 7-14. Retrieved May 5, 2017, from

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854576/.

6. Wilson, R. (2017, March 08). Amid federal uncertainty, states confront opioid crisis. Retrieved June 02, 2017, from http://thehill.com/homenews/state-watch/323021-amid-federal-uncertainty-states-confront-opioid-crisis

7. Prevoznik, T., & Drug Enforcement Administration. (n.d.). Drug Trends. Pharmacy Diversion Awareness Conference. doi:https://www.deadiversion.usdoj.gov/mtgs/pharm_awareness/conf_2015/december_2015/index.html

8. CBS4. (2011, January 18). Kristen Parker Appeals For Lighter Sentence. Retrieved May 05, 2017, from http://denver.cbslocal.com/2011/01/18/kristen-parker-appeals-for-lighter-sentence/